The positive impact of rituximab on the quality of life and mental health in patients with pemphigus

Hanan Rashid; Mila Poelhekken; Joost M. Meijer; Maria C. Bolling; Barbara Horváth

doi:10.1016/j.jdin.2022.01.004

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus

Hanan Rashid^*, Mila Poelhekken, Joost M. Meijer, Maria C. Bolling, Barbara Horváth

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	31-33
Number of pages	3
Journal	JAAD international
Volume	7
DOIs	https://doi.org/10.1016/j.jdin.2022.01.004
Publication status	Published - Jun-2022

Keywords

DLQI
mental health
pemphigus
quality of life
rituximab
TABQOL

Access to Document

10.1016/j.jdin.2022.01.004Licence: CC BY

The positive impact of rituximab on the quality of life and mental health in patients with pemphigusFinal publisher's version, 73.5 KBLicence: CC BY

Cite this

@article{13cb668a950d4f7181ba7e73ce5b5c81,

title = "The positive impact of rituximab on the quality of life and mental health in patients with pemphigus",

keywords = "DLQI, mental health, pemphigus, quality of life, rituximab, TABQOL",

author = "Hanan Rashid and Mila Poelhekken and Meijer, {Joost M.} and Bolling, {Maria C.} and Barbara Horv{\'a}th",

note = "Funding Information: Permission to use the licensed tool TABQOL was obtained from the Australasian Blistering Diseases Foundation. Funding sources: None.",

year = "2022",

month = jun,

doi = "10.1016/j.jdin.2022.01.004",

language = "English",

volume = "7",

pages = "31--33",

journal = "JAAD international",

issn = "2666-3287",

}

TY - JOUR

T1 - The positive impact of rituximab on the quality of life and mental health in patients with pemphigus

AU - Rashid, Hanan

AU - Poelhekken, Mila

AU - Meijer, Joost M.

AU - Bolling, Maria C.

AU - Horváth, Barbara

N1 - Funding Information: Permission to use the licensed tool TABQOL was obtained from the Australasian Blistering Diseases Foundation. Funding sources: None.

PY - 2022/6

Y1 - 2022/6

KW - DLQI

KW - mental health

KW - pemphigus

KW - quality of life

KW - rituximab

KW - TABQOL

U2 - 10.1016/j.jdin.2022.01.004

DO - 10.1016/j.jdin.2022.01.004

M3 - Letter

AN - SCOPUS:85125713265

VL - 7

SP - 31

EP - 33

JO - JAAD international

JF - JAAD international

SN - 2666-3287

ER -